• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Vu Q&A Page 5

Vu Q&A

July 11, 2019

Vu Q&A: Sonia Canzater and Jeff Crowley on Hepatitis C and the Ryan White HIV/AIDS Program

June 12, 2019

Vu Q&A: Michelle Rose on Perinatal Hepatitis C Transmission in Kentucky

Read More

June 5, 2019

Vu Q&A: Shauna Onofrey on Hepatitis C Elimination Efforts in Massachusetts

Read More

May 14, 2019

Vu Q&A: Guillermo Chacón on Hepatitis among Hispanics/Latinx

Read More

May 6, 2019

Vu Q&A: Lindsey Dawson on Hepatitis C, HIV, and Health Insurance

Read More

January 15, 2019

Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.

Read More

June 20, 2018

Vu Q&A: Testing Vulnerable Populations in the Emergency Room

Read More

May 29, 2018

Vu Q&A: The Opioid Epidemic and Viral Hepatitis in Appalachia

Read More

May 15, 2018

Vu Q&A: Using Storytelling to Reduce Hepatitis B Stigma

Read More

May 15, 2018

Vu Q&A: Fighting Back Against Viral Hepatitis in Hawaii

  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2026 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.